Cerebral complications constitute the leading source of morbidity and disability after cardiac operations. The incidence of stroke after coronary artery bypass grafting has increased in tandem with the mean age of the patient population. Although many cerebral deficits resolve with time, others remain sources of disability for otherwise functional patients and detract from an otherwise successful procedure. The clinical spectrum of cerebral complications includes both neurologic and neuropsychologic deficits. Neurologic deficits include fatal cerebral injury, stroke, impaired level of consciousness, and seizures. The incidence of these deficits is 1% to 6%. Neuropsychologic deficits refer to cognitive changes, and are quantitated with tests of memory and learning and speed of visual-motor response. The incidence of these deficits is 60% to 80% at 1 week after operation and 20% to 40% at 8 weeks after operation. Central nervous system complications after cardiac operations have been attributed in large part to the effects of cardiopulmonary bypass on the brain. Potential mechanisms include macroembolization of air or particulate matter, microembolization of gas, fat, aggregates of blood cells, platelets or fibrin, and particles of silicone or polyvinylchloride tubing; and inadequate cerebral perfusion pressure. Methods of assessment include those applied during the procedure (clinical observation, assessment of cerebral blood flow and metabolism, intraoperative electroencephalography, transcranial and carotid Doppler echography, quantitative embolic measurement, and fluorescein angiography) and those performed to measure outcome (neurologic and neuropsychologic testing, computed tomographic scans, magnetic resonance imaging, and cerebrospinal fluid studies). Much of the literature regarding cerebral injury and cardiopulmonary bypass is descriptive, relating patient risk factors to the incidence of postoperative stroke. A limited but growing body of work seeks to prospectively examine patients and identify interventions that will reduce the incidence and severity of central nervous system complications.
